What is the official ID of this bill?
The official print number for this legislation is S 464.
Easier Drug Access: Ending Unnecessary Step Therapy Trials
New rules make it easier for patients to get the medications their doctor deems best, without having to go through ineffective or harmful treatments first. Health insurers must implement clear processes for patients to appeal step therapy requirements, with faster decisions, especially in emergencies. This means treatment will be more tailored to individual needs, and patients will receive appropriate help more quickly.
Key points
Health insurers must establish an appeal process for step therapy requirements before accessing prescribed medications.
Patients can appeal if previous drugs were ineffective, harmful, treatment delay poses serious consequences, or if the drug is essential for daily functioning.
Appeal decisions will be made quickly: within 72 hours for standard cases and 24 hours for life-threatening emergencies.
Information about the appeal process must be readily available on health insurers' websites.
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens
(explained here).
Start recording it now.